Match tier
Likely match
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-08
S
Sanjay Adhikary
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Graduate Assistant
2 h-index
9 pubs
12 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Sanjay Adhikary's research focuses on the investigation of potential therapeutic agents, particularly in the context of melanoma treatment. His work includes exploring the antimicrobial properties of plant extracts, such as those from Verbena officinalis. Adhikary has also synthesized and studied novel thiazole-fused bisnoralcohol derivatives and thiazole-fused androstenone and ethisterone derivatives, identifying them as potent inhibitors of the β- and γ-actin cytoskeleton, which may be relevant for treating melanoma tumors. His recent publications also touch upon the role of ATF6 activation in promoting immune checkpoint blockade (ICB) response in melanoma. Adhikary has collaborated with researchers from Arkansas State University and the University of Arkansas for Medical Sciences on multiple publications. His scholarship metrics include an h-index of 2, with 9 total publications and 12 total citations.
Metrics
- h-index: 2
- Publications: 9
- Citations: 12
Positions
-
Graduate Assistant publications 2025–2026University of Arkansas for Medical Sciences Institution web page
Selected Publications
-
Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy (2026)
-
691 ATF6 activation promotes ICB response in melanoma (2025)
-
Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors (2025)
-
Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors (2024)
-
Efficient Synthesis of Thiazole-Fused Bisnoralcohol Derivatives as Potential Therapeutic Agents (2024)
-
In Vitro Antimelanoma Properties of Verbena officinalis Fractions (2022)
Collaboration Network
Top Collaborators
Mohammad A. Alam
Arkansas State University
4 shared publications
In database
- In Vitro Antimelanoma Properties of Verbena officinalis Fractions
- Efficient Synthesis of Thiazole-Fused Bisnoralcohol Derivatives as Potential Therapeutic Agents
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
Nathan L. Avaritt
University of Arkansas for Medical Sciences
4 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- 691 ATF6 activation promotes ICB response in melanoma
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Subrata Roy
Arkansas State University
3 shared publications
In database
- Efficient Synthesis of Thiazole-Fused Bisnoralcohol Derivatives as Potential Therapeutic Agents
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
Alan J. Tackett
University of Arkansas for Medical Sciences
3 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Shailesh Budhathoki
Arkansas State University
2 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
Alexei G. Basnakian
Central Arkansas Veterans Healthcare System
2 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
Mohamed Milad
Arkansas State University
2 shared publications
In database
- Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
- Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors
Jacob L Edmondson
University of Arkansas for Medical Sciences
2 shared publications
In database
- 691 ATF6 activation promotes ICB response in melanoma
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Daniel Fil
University of Arkansas for Medical Sciences
2 shared publications
In database
- 691 ATF6 activation promotes ICB response in melanoma
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Megan R. Reed
University of Arkansas for Medical Sciences
2 shared publications
In database
- 691 ATF6 activation promotes ICB response in melanoma
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Billie Heflin
University of Arkansas for Medical Sciences
2 shared publications
In database
- 691 ATF6 activation promotes ICB response in melanoma
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Katherine Wallis
University of Arkansas for Medical Sciences
2 shared publications
In database
- 691 ATF6 activation promotes ICB response in melanoma
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Brian Koss
University of Arkansas for Medical Sciences
2 shared publications
In database
- 691 ATF6 activation promotes ICB response in melanoma
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Rabia Nisar
Islamia University of Bahawalpur (PK)
1 shared publication
- In Vitro Antimelanoma Properties of Verbena officinalis Fractions
Saeed Ahmad
Islamia University of Bahawalpur (PK)
1 shared publication
- In Vitro Antimelanoma Properties of Verbena officinalis Fractions
Similar Researchers
Based on overlapping research topics
Mousumi Patra
University of Arkansas for Medical Sciences
Phytochemicals and Antioxidant Activities
Cancer-related molecular mechanisms research
Drug Delivery Systems
Tra Le
Arkansas State University
Cancer Treatment and Pharmacology
Phytochemicals and Antioxidant Activities
Cancer-related molecular mechanisms research
Alexx Weaver
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Phytochemicals and Antioxidant Activities
Cancer-related molecular mechanisms research
Fumou Sun
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Phytochemicals and Antioxidant Activities
Cancer-related molecular mechanisms research
Mahfuzul Hassan
Philander Smith College
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Drug Delivery Systems
Shahedur Rahman
University of Arkansas at Little Rock
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Drug Delivery Systems